Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34

The randomized controlled Pediatric Oncology Group study 9233 tested the hypothesis that dose-intensive (DI) chemotherapy would improve event-free survival (EFS) for children

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuro-oncology (Charlottesville, Va.) Va.), 2014-03, Vol.16 (3), p.457-465
Hauptverfasser:	Strother, Douglas R, Lafay-Cousin, Lucie, Boyett, James M, Burger, Peter, Aronin, Patricia, Constine, Louis, Duffner, Patricia, Kocak, Mehmet, Kun, Larry E, Horowitz, Marc E, Gajjar, Amar
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - therapeutic use Brain Neoplasms - drug therapy Child, Preschool Ependymoma - drug therapy Female Humans Infant Male Medulloblastoma - drug therapy Pediatric Neuro-Oncology Supratentorial Neoplasms - drug therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The randomized controlled Pediatric Oncology Group study 9233 tested the hypothesis that dose-intensive (DI) chemotherapy would improve event-free survival (EFS) for children
ISSN:	1522-8517 1523-5866
DOI:	10.1093/neuonc/not163